140 related articles for article (PubMed ID: 19568710)
1. Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage.
Du QC; Yang KZ; Sun XF
Chin J Integr Med; 2009 Jun; 15(3):184-8. PubMed ID: 19568710
[TBL] [Abstract][Full Text] [Related]
2. Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC.
Masotti A; Morandini G; Ortolani R; Fumagalli L
Lung Cancer; 1998 Jun; 20(3):191-202. PubMed ID: 9733054
[TBL] [Abstract][Full Text] [Related]
3. Application of Aidi injection (艾迪注射液) in the bronchial artery infused neo-adjuvant chemotherapy for stage III A non-small cell lung cancer before surgical operation.
Sun XF; Pei YT; Yin QW; Wu MS; Yang GT
Chin J Integr Med; 2010 Dec; 16(6):537-41. PubMed ID: 21110180
[TBL] [Abstract][Full Text] [Related]
4. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
[TBL] [Abstract][Full Text] [Related]
5. Effect of compound Kushen injection on T-cell subgroups and natural killer cells in patients with locally advanced non-small-cell lung cancer treated with concomitant radiochemotherapy.
Zhao Z; Liao H; Ju Y
J Tradit Chin Med; 2016 Feb; 36(1):14-8. PubMed ID: 26946613
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Microwave Ablation Combined with Anti-PD-1 Monoclonal Antibody on T Cell Subsets and Long-Term Prognosis in Patients Suffering from Non-Small-Cell Lung Cancer.
Yu W; Sun J; Wang T; Du Y
Comput Math Methods Med; 2022; 2022():7095423. PubMed ID: 36199771
[TBL] [Abstract][Full Text] [Related]
7. Clinical observation of Yiqi Qingdu prescription on the treatment of intermediate-stage and advanced non-small-cell lung cancer.
Liang Q; Tang X; Yu J; Xiong M; Zhu H; Xiong L; Zeng R; Yu P
J Tradit Chin Med; 2021 Apr; 41(2):308-315. PubMed ID: 33825412
[TBL] [Abstract][Full Text] [Related]
8. [Effects of early intestinal application of sijunzi decoction on immune function in post-operational patients of gastrointestinal tumor].
Liang C; Zhang SH; Cai ZD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1070-3. PubMed ID: 16398424
[TBL] [Abstract][Full Text] [Related]
9. Effect of Wuye Decoction on lymphocyte phenotype in patients with non-small cell lung cancer.
Zheng SL; Yang QS; Ma XH
Chin J Integr Med; 2006 Jun; 12(2):118-21. PubMed ID: 16800990
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory Effect of Lentinan on Aberrant T Subsets and Cytokines Profile in Non-small Cell Lung Cancer Patients.
Wang XE; Wang YH; Zhou Q; Peng M; Zhang J; Chen M; Ma LJ; Xie GM
Pathol Oncol Res; 2020 Jan; 26(1):499-505. PubMed ID: 30460541
[TBL] [Abstract][Full Text] [Related]
11. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced
Non-small Cell Lung Cancer and Its Therapeutic Effect].
Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with non‑small cell lung cancer: A comparative study.
Xu Q; Shi NJ; Zhang H; Zhu YM
Mol Med Rep; 2017 Oct; 16(4):4445-4454. PubMed ID: 28765974
[TBL] [Abstract][Full Text] [Related]
13. Impact of allogenic and autologous transfusion on immune function in patients with tumors.
Guo JR; Xu F; Jin XJ; Shen HC; Liu Y; Zhang YW; Shao Y
Asian Pac J Cancer Prev; 2014; 15(1):467-74. PubMed ID: 24528076
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum inflammatory factors, adiponectin, intestinal flora and immunity in patients with non-small cell lung cancer.
Wang RP; Wang XH; Li ZM; Sun JR
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10566-10572. PubMed ID: 33155213
[TBL] [Abstract][Full Text] [Related]
15. [Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].
Duan X; Cui Y; Gong M; Tian F; Shi G; Wu B; Liu M; Guo J; Kong Y
Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):358-64. PubMed ID: 26104892
[TBL] [Abstract][Full Text] [Related]
16. [Effect of combination of syndrome differentiation depending treatment and chemotherapy on prognostic factors in treating mid-late patients with non-small call lung cancer].
Li LN; Liu WS; Xu K
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):575-9. PubMed ID: 14503053
[TBL] [Abstract][Full Text] [Related]
17. The distribution and function of human memory T cell subsets in lung cancer.
Sheng SY; Gu Y; Lu CG; Zou JY; Hong H; Wang R
Immunol Res; 2017 Jun; 65(3):639-650. PubMed ID: 28101811
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on inflammatory factors and immune functions of lung cancer and pulmonary ground-glass attenuation.
Liu CY; Xie WG; Wu S; Tian JW; Li J
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4098-4103. PubMed ID: 29028090
[TBL] [Abstract][Full Text] [Related]
19. Clinical Efficacy and Gut Microbiota Regulating-Related Effect of Si-Jun-Zi Decoction in Postoperative Non-Small Cell Lung Cancer Patients: A Prospective Observational Study.
He Y; Qi A; Gu Y; Zhang C; Wang Y; Yang W; Bi L; Gong Y; Jiao L; Xu L
Integr Cancer Ther; 2024; 23():15347354241237973. PubMed ID: 38504436
[TBL] [Abstract][Full Text] [Related]
20. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
